Neurologic manifestations associated with the Zika virus encompass a large group of clinical neurologic manifestations. Researchers found a modified Rankin scale score may help identify the risk for mechanical ventilation in certain patients with the virus.
Jonathan Miner, MD, PhD, and Karin Nielsen-Saines, MD, MPH, discuss the latest insights about neurologic complications of ZVI and knowledge gaps that still exist in this field.
Pregnant women placed a high premium on clinical evidence when considering whether or not to participate in a hypothetic clinical trial of a Zika virus vaccine.
The most cost-effective means of decreasing transmission of Zika virus is administration of the vaccine to young adults and women of childbearing age.
In an updated interim guidance, the CDC now recommends that couples wait at least 3 months before attempting to conceive after possible Zika virus exposure in the male.
The ZIK-101 trial has enrolled 240 adults to test the safety and immunogenicity of TAK-426.
Findings allow for anticipation of medical and social service needs of affected children and their families.
This surveillance also spotted an increase in mosquitoes that transmit dengue and chikungunya viruses.
The CDC report also says that too few infants are tested for the virus.
Steps are being taken to protect patients who need transfusions.
